Aquatic Capital Management’s Rhythm Pharmaceuticals RYTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-19,754
Closed -$2.19M – 1651
2026
Q2
$2.19M Sell
19,754
-9,917
-33% -$897K 0.08% 343
2026
Q1
$2.58M Buy
+29,671
New +$2.89M 0.07% 325
2025
Q4
– Sell
-42,490
Closed -$4.29M – 1722
2025
Q3
$4.29M Buy
42,490
+38,537
+975% +$3.58M 0.08% 301
2025
Q2
$250K Sell
3,953
-37,523
-90% -$2.3M 0.01% 980
2025
Q1
$2.2M Buy
41,476
+32,253
+350% +$1.79M 0.06% 393
2024
Q4
$516K Buy
+9,223
New +$509K 0.01% 708
2024
Q2
– Sell
-8,600
Closed -$373K – 1548
2024
Q1
$373K Buy
+8,600
New +$376K 0.01% 615
2023
Q4
– Sell
-3,100
Closed -$71K – 1589
2023
Q3
$71K Buy
+3,100
New +$69.4K ﹤0.01% 899
2022
Q3
– Sell
-2,300
Closed -$10K – 1497
2022
Q2
$10K Buy
2,300
+2,000
+667% +$10.9K ﹤0.01% 971
2022
Q1
$3K Sell
300
-3,700
-93% -$32.5K ﹤0.01% 926
2021
Q4
$40K Buy
+4,000
New +$44.9K 0.08% 374

Other funds holding RYTM

Aquatic Capital Management's RYTM Position: Q3 2026 in Review

Aquatic Capital Management sold out of Rhythm Pharmaceuticals (RYTM) in Q3 2026, closing a stake of 19,754 shares — an estimated $2.19M sold.

Aquatic Capital Management first reported a position in RYTM in Q4 2021 and held it in 11 quarters. The position peaked at $4.29M in Q3 2025. 333 funds tracked by Wall St. Rank hold RYTM as of Q3 2026.

  • Aquatic Capital Management reported no remaining Rhythm Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • Aquatic Capital Management sold 19,754 Rhythm Pharmaceuticals shares in Q3 2026, an estimated $2.19M.
  • Aquatic Capital Management first reported a position in Rhythm Pharmaceuticals in Q4 2021 and held it in 11 quarters.
  • Aquatic Capital Management's Rhythm Pharmaceuticals position peaked at $4.29M in Q3 2025.
  • 333 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2026.

Based on Aquatic Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.